Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

BIOLOGICAL(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04934774Phase 1Unknown
Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-cell Non-Hodgkin Lymphoma
PrincipalinvestigatorStart date: 2020-12-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Peking University Shenzhen Hospital, China

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Allyson Flower, MD

New York Medical College

Related
1 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Lymphoma
Similarity Score20%

Hongyu Zhang, MD/PhD

Peking University Shenzhen Hospital, China

Related
3 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-Cell Non-Hodgkin Lymphoma

Worked with same sponsors:

iCAR Bio Therapeutics Ltd.iCell Gene Therapeutics+1 more
Similarity Score20%

LaQuisa Hill, MD

The Methodist Hospital Research Institute

Related
3 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Lymphoma
Similarity Score20%

Wang Xingbing

The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)

Related
1 trials

Shared therapeutic areas:

T-cell Acute Lymphoblastic LymphomaT-Cell Non-Hodgkin Lymphoma
Similarity Score20%

Troy Quigg, DO

Helen DeVos Children's Hospital

Related
1 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Lymphoma
Similarity Score20%

Mitchell Cairo, MD

New York Medical College

Related
14 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Lymphoma
Similarity Score20%

Rayne Rouce, MD

Baylor College of Medicine

Related
3 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Lymphoma
Similarity Score20%

Rayne Rouce, MD

Pediatrics, Baylor College of Medicine

Related
1 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Lymphoma
Similarity Score20%

Noelle Frey, MD

University of Pennsylvania

Related
5 trials

Shared therapeutic areas:

T-Cell Non-Hodgkin Lymphoma
Similarity Score10%

Issa Khouri, MD

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

T-Cell Non-Hodgkin Lymphoma
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04934774Phase 1PrincipalInvestigator

Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances

T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-cell Non-Hodgkin Lymphoma
Unknown

All 1 trials loaded